Longitudinal Spatiotemporal Distribution of Gray and White Matter Pathology in Multiple Sclerosis

References

1. 1.↵
   1. Filippi M,
   2. Rocca MA

   . MR imaging of gray matter involvement in multiple sclerosis: implications for understanding disease pathophysiology and monitoring treatment efficacy. AJNR Am J Neuroradiol 2009 Dec 31. [Epub ahead of print]
2. 2.↵
   1. Sepulcre J,
   2. Goni J,
   3. Masdeu JC,
   4. et al

   . Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. Arch Neurol 2009; 66: 173– 79

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Bendfeldt K,
   2. Kuster P,
   3. Traud S,
   4. et al

   . Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis: a longitudinal voxel-based morphometry study. Neuroimage 2009;45:60–67

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Bendfeldt K,
   2. Blumhagen JO,
   3. Egger H,
   4. et al

   . Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional gray matter volume reductions in relapsing-remitting multiple sclerosis. Human Brain Mapping. 2010 Jan 27 [Epub ahead of print]